Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial

被引：27
作者：
Spaner, David E. [1 ,2 ,3 ,4 ,5 ]
Wang, Guizhei [1 ]
McCaw, Lindsay [1 ]
Li, Yanmei [1 ]
Disperati, Patricia [6 ]
Cussen, Mary-Ann [3 ]
Shi, Yonghong [1 ]
机构：
[1] Sunnybrook Res Inst, Biol Platform, Toronto, ON, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada
[3] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[4] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada
[5] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada
[6] Toronto East Gen Hosp, Toronto, ON, Canada
来源：
HAEMATOLOGICA | 2016年 / 101卷 / 05期
关键词：
chronic lymphocytic leukemia; Janus Kinases; STAT3; Ruxolitinib; Ibrutinib; Kinase inhibitors; phosphoproteome; FOLLOW-UP; RESISTANCE; THERAPY; CELLS; CLL;
D O I：
10.3324/haematol.2015.135418
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 15 条
  • [1] Three-year follow-up of treatment-naive and previously treated patients with CLL and SLL receiving single-agent ibrutinib
    Byrd, John C.
    Furman, Richard R.
    Coutre, Steven E.
    Burger, Jan A.
    Blum, Kristie A.
    Coleman, Morton
    Wierda, William G.
    Jones, Jeffrey A.
    Zhao, Weiqiang
    Heerema, Nyla A.
    Johnson, Amy J.
    Shaw, Yun
    Bilotti, Elizabeth
    Zhou, Cathy
    James, Danelle F.
    O'Brien, Susan
    [J]. BLOOD, 2015, 125 (16) : 2497 - 2506
  • [2] Chronic lymphocytic leukemia in less fit patients: "slow-go"
    Del Giudice, Ilaria
    Mauro, Francesca Romana
    Foa, Robin
    [J]. LEUKEMIA & LYMPHOMA, 2011, 52 (12) : 2207 - 2216
  • [3] Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy
    Ebos, John M. L.
    Lee, Christina R.
    Christensen, James G.
    Mutsaers, Anthony J.
    Kerbel, Robert S.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (43) : 17069 - 17074
  • [4] Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia
    Eghtedar, Alireza
    Verstovsek, Srdan
    Estrov, Zeev
    Burger, Jan
    Cortes, Jorge
    Bivins, Carol
    Faderl, Stefan
    Ferrajoli, Alessandra
    Borthakur, Gautam
    George, Solly
    Scherle, Peggy A.
    Newton, Robert C.
    Kantarjian, Hagop M.
    Ravandi, Farhad
    [J]. BLOOD, 2012, 119 (20) : 4614 - 4618
  • [5] DETERMINATION OF NUMBER OF PATIENTS REQUIRED IN A PRELIMINARY AND A FOLLOW-UP TRIAL OF A NEW CHEMOTHERAPEUTIC AGENT
    GEHAN, EA
    [J]. JOURNAL OF CHRONIC DISEASES, 1961, 13 (04): : 346 - &
  • [6] Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
    Hallek, Michael
    Cheson, Bruce D.
    Catovsky, Daniel
    Caligaris-Cappio, Federico
    Dighiero, Guillaume
    Doehner, Hartmut
    Hillmen, Peter
    Keating, Michael J.
    Montserrat, Emili
    Rai, Kanti R.
    Kipps, Thomas J.
    [J]. BLOOD, 2008, 111 (12) : 5446 - 5456
  • [7] JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
    Harrison, Claire
    Kiladjian, Jean-Jacques
    Al-Ali, Haifa Kathrin
    Gisslinger, Heinz
    Waltzman, Roger
    Stalbovskaya, Viktoriya
    McQuitty, Mari
    Hunter, Deborah S.
    Levy, Richard
    Knoops, Laurent
    Cervantes, Francisco
    Vannucchi, Alessandro M.
    Barbui, Tiziano
    Barosi, Giovanni
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) : 787 - 798
  • [8] Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?
    Heine, Annkristin
    Brossart, Peter
    Wolf, Dominik
    [J]. BLOOD, 2013, 122 (23) : 3843 - 3844
  • [9] Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A
    Li, Yanmei
    Shi, Yonghong
    Mccaw, Lindsay
    Li, You-Jun
    Zhu, Fang
    Gorczynski, Reg
    Duncan, Gordon S.
    Yang, Burton
    Ben-David, Yaacov
    Spaner, David E.
    [J]. BLOOD, 2015, 126 (06) : 766 - 778
  • [10] Outcome of Patients with Philadelphia Negative B-Cell Acute Lymphoblastic Leukemia (ALL) and Isolated Central Nervous System (CNS) Relapse
    Montalban-Bravo, Guillermo
    Kantarjian, Hagop M.
    Jain, Punit L.
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Cortes, Jorge E.
    Daver, Naval
    Takahashi, Koichi
    Jain, Nitin
    Verstovsek, Srdan
    Kadia, Tapan
    Pierce, Sherry
    Jabbour, Elias
    [J]. BLOOD, 2015, 126 (23)
12